Masahide Yamamoto

8PUBLICATIONS
45CO-AUTHORS
Gene and molecular therapyCancer therapy (excl. chemotherapy and radiation therapy)Respiratory diseasesHaematologyMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 07, 2026
Delayed-onset parkinsonism possibly associated with elranatamab treatment for relapsed/refractory multiple myeloma: a case report of a poorly characterized neurological event.

|Jun 18, 2026
Treatment-Free Remission and Immune Profiling after Frontline Second-Generation TKI Therapy in CML.

|May 11, 2026
Clinical features and prognostic factors of adult systemic chronic active EBV disease: A retrospective analysis in Japan.

|Jan 20, 2026
Induction chemotherapy with methotrexate, nimustine, and procarbazine for primary CNS lymphoma in the elderly: a retrospective evaluation of safety and efficacy.

Yoshihiro Umezawa, Masahide Yamamoto, Keisuke Tanaka

|Aug 06, 2025
Management of inpatient chimeric antigen receptor T-cell therapy for relapsed/refractory B-cell malignancies: an analysis using the Japanese Diagnosis Procedure Combination database.

Keisuke Tanaka, Hiroaki Kikuchi, Yoshihiro Umezawa

|Mar 21, 2024
Impact of BK polyomavirus viremia on the outcomes of allogeneic hematopoietic stem cell transplantation.

Yoshihiro Umezawa, Kota Yoshifuji, Keisuke Tanaka

Pageof 2

Frequent Collaborators

4 joint publications

Yoshihiro Umezawa

3 joint publications

Keisuke Tanaka

3 joint publications

Takehiko Mori

2 joint publications

Kota Yoshifuji